Obermatt

Cabot

NYQ:CBT · US1270551013
ChemicalsLarge

360

75
EV / EBIT75
Price / Owner Earnings26
Owner Earnings Yield77
Dividend Yield75
Price/Sales53
EV / Gross Profit53
Price/Book33
Return on Capital88
Cash Return on Capital84
Return on Equity92
EBIT Margin90
Gross Profitability72
Cash Conversion60
Accruals65
Owner Earnings Margin79
Sales growth4
Profit Growth61
Long-Term EPS Growth52
Owner Earnings Growth36
Reinvestment16
Price momentum47
Debt load60
Refinancing61
Debt Payback44
Liquidity73
Analyst ratings12
Opinion Changes50
Price Target Upside14
Market mood100
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Cabot clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryChemicals
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1960
Employees2,395
ISINUS1270551013
Last UpdateApr 2, 2026
Themes
Battery Energy Storage System (BESS)Bio-based and Renewable MaterialsCleanTechEnergy StoragePackaging ServicesElectric VehicleClimateTech

Description

Cabot Corporation (Cabot) is a global specialty chemicals and performance materials company. The company’s principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, ink…

Analysis

Quality compounder

Cabot Corporation earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess.

On valuation, the picture is fair. The owner-earnings multiple stands at 20.5×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 7% a year, against analyst forecasts of 1%. The gap between price and consensus is worth watching: demanding expectations.

Growth is tepid; the safety picture is sturdy. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
65
2023202420252026

All-time high

98

Jan 2024

All-time low

47

Mar 2026

Average rank

82

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
53
63
58
79
Price/Earnings
56
86
71
67
Price/Book
33
47
28
50
Dividend Yield
75
74
70
69
Value (overall)
54
84
61
73

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Cabot with its peers
Trinseo
NYQ:TSE
5
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Albemarle
NYQ:ALB
62
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
NewMarket
NYQ:NEU
68
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Stepan
NYQ:SCL
21
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Avient
NYQ:AVNT
52
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Koppers
NYQ:KOP
80
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →